Milestone Pharmaceuticals Inc

NASDAQ:MIST  
4.06
-0.32 (-7.31%)
6:49:07 PM EDT: $4.19 +0.13 (+3.20%)
Earnings Announcements

Milestone Pharmaceuticals Reports Q3 Loss Of $0.34 Per Share

Published: 11/10/2022 13:11 GMT
Milestone Pharmaceuticals Inc (MIST) - Milestone Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Clinical and Corporate Update.
Qtrly Loss per Share $0.34.
Q3 Earnings per Share View $-0.41 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $1.17 Million
Adjusted EPS is expected to be -$0.34

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.37

More details on our Analysts Page.